ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Smith and Nephew Plc New

Smith and Nephew Plc New (SNN)

29,95
-0,53
(-1,74%)
Beim Schlusskurs: 08 Juli 10:00PM
29,95
0,00
( 0,00% )
Nach Börsenschluss: 10:25PM

Smith and Nephew Plc New (SNN) Aktie

Professionelle Tools für Privatanleger.

Premium

Wichtige Statistiken und Details

Current Price
29,95
( -1,74% )
Gebot
-
Fragen
-
Volumen
983.296
Durchschnittliches Volumen (3 Mio.)
US$ 3.070.503
Finanzvolumen
US$ 29.585.693
29,92 Tagesbereich 30,205
28,555 52-Wochen-Bereich 38,79
Marktkapitalisierung
Unternehmenswert
15,539B
Handelsende
30,48
Handelsbeginn
30,11
Letzte Trade
1
@
29.95
Letzter Handelszeitpunkt
22:10:04
VWAP
30,0883
Erlöse (LTM)
6,16B
Nettogewinn (LTM)
625M
Ausgegebene Aktien
848.450.481
Streubesitz (%)
98,85%
Institutioneller Besitz (%)
89,00%
Dividendenrendite (LTM)
0,39
Kurs-Gewinn-Verhältnis
21,02
Kurs-Umsatz-Verhältnis (KUV)
2,07
Gewinn pro Aktie (EPS)
0,72
Beta
0,68

Über Smith and Nephew Plc New

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It of... Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. The company also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, it provides arthroscopic enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, the company offers advanced wound care products for the treatment and prevention of acute and chronic wounds, leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom. Mehr anzeigen

Sektor
Healthcare
Branche
Medical Equipment & Supplies
Hauptsitz
Watford, United Kingdom
Gegründet
2026
Smith and Nephew Plc New is listed in the Healthcare sector of the New York Börse with ticker SNN. The last closing price for Smith and Nephew was US$30,48. Over the last year, Smith and Nephew shares have traded in a share price range of US$ 28,555 to US$ 38,79.

Smith and Nephew currently has 848.450.481 shares in issue. The market capitalisation of Smith and Nephew is US$25,41 billion. Smith and Nephew has a price to earnings ratio (PE ratio) of 21.02.

SNN Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.963.3114867195628.9931.0328.73151197629.80970224DR
4-1.23-3.9448364336131.1831.3828.555135641529.8786069DR
12-4.73-13.638985005834.6834.72528.555131282930.57858445DR
26-3.59-10.703637447833.5437.0928.555108504532.04461456DR
520.331.1141120864329.6238.7928.55591124932.9235463DR
1560.010.033400133600529.9438.7921.52591911728.65365498DR
260-13.23-30.639184807843.1844.221.52588091729.06618198DR

SNN - Frequently Asked Questions (FAQ)

What is the current Smith and Nephew Plc New share price?
The current share price of Smith and Nephew Plc New is US$ 29,95
How many Smith and Nephew Plc New shares are in issue?
Smith and Nephew Plc New has 848.450.481 shares in issue
What is the market cap of Smith and Nephew Plc New?
The market capitalisation of Smith and Nephew Plc New is USD 25,41B
What is the 1 year trading range for Smith and Nephew Plc New share price?
Smith and Nephew Plc New has traded in the range of US$ 28,555 to US$ 38,79 during the past year
What is the PE ratio of Smith and Nephew Plc New?
The price to earnings ratio of Smith and Nephew Plc New is 21,02
What is the cash to sales ratio of Smith and Nephew Plc New?
The cash to sales ratio of Smith and Nephew Plc New is 2,07
What is the registered address of Smith and Nephew Plc New?
The registered address for Smith and Nephew Plc New is Building 5, Watford, Hertfordshire, WD18 8YE
What is the Smith and Nephew Plc New website address?
The website address for Smith and Nephew Plc New is www.smith-nephew.com
Which industry sector does Smith and Nephew Plc New operate in?
Smith and Nephew Plc New operates in the Medical Equipment & Supplies sector

SNN Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen